project id: TCGA-UCEC; case submitter id: TCGA-EY-A212; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.7; rna integrity number: 8.8; spectrophotometer method: UV Spec; age at index: 83; days to birth: -30680; days to death: 310; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1927; age at diagnosis: 30680; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 110.0; figo stage: Stage IIIC1; icd 10 code: C54.1; last known disease status: not reported; morphology: 8460/3; primary diagnosis: Papillary serous cystadenocarcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: Not Reported; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 112; days to sample procurement: 0; initial weight: 290.0; portion submitter id: TCGA-EY-A212-01A-11; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 5.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0;